Parkman Healthcare Partners LLC
Filing Date
Global Rank
#1,995
/ 8,700
▲ 411
Top Industry
Biotechnology
53.0%
Period ended 2 months ago
Filed Aug 14, 2026 · 30d
26 quarters · since Mar 2020
Portfolio Concentration
76 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
4.6%
−1.0 pts
Top 5
20.6%
−0.1 pts
Top 10
34.0%
−1.7 pts
HHI
219
Diversified−1
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 98.7% | $950,673,192 |
| Industrials | 0.8% | $7,980,686 |
| Unclassified | 0.5% | $4,587,579 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc.\DE | +819,640 | 1,377,576 | $25,306,071 | |
| FDMT | 4D Molecular Therapeutics, Inc. | +425,607 | 948,184 | $12,610,847 | |
| ASMB | Assembly Biosciences, Inc. | +309,954 | 721,181 | $19,818,053 | |
| AGIO | Agios Pharmaceuticals, Inc. | +265,521 | 669,046 | $24,828,297 | |
| EWTX | Edgewise Therapeutics, Inc. | +254,208 | 577,036 | $23,444,972 | |
| GPCR | Structure Therapeutics Inc. | +253,568 | 485,661 | $26,065,425 | |
| AMRX | Amneal Pharmaceuticals, Inc. | +240,438 | 541,190 | $9,367,998 | |
| IMNM | Immunome Inc. | +190,715 | 594,202 | $12,591,140 | |
| DRUG | Bright Minds Biosciences Inc. | +164,955 | 205,053 | $14,394,720 | |
| COGT | Cogent Biosciences, Inc. | +153,239 | 253,365 | $9,805,225 | |
| UPB | Upstream Bio, Inc. | +148,464 | 935,247 | $6,471,909 | |
| XERS | Xeris Biopharma Holdings, Inc. | +86,357 | 1,807,621 | $14,316,358 | |
| CARL | Carlsmed, Inc. | +76,195 | 597,318 | $6,200,160 | |
| THC | Tenet Healthcare Corp | +47,157 | 97,280 | $18,199,142 | |
| IRTC | iRhythm Holdings, Inc. | +27,142 | 67,267 | $8,001,409 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | +23,756 | 50,672 | $15,253,792 | |
| IQV | Iqvia Holdings Inc. | +19,109 | 105,811 | $20,444,801 | |
| STOK | Stoke Therapeutics, Inc. | +18,924 | 355,443 | $11,630,094 | |
| CSTL | Castle Biosciences Inc | +18,641 | 144,791 | $3,453,265 | |
| ALGN | Align Technology Inc | +15,730 | 36,963 | $6,234,179 | |
| CVS | CVS HEALTH Corp | +4,485 | 391,791 | $40,530,778 | |
| PTCT | Ptc Therapeutics, Inc. | +4,327 | 435,691 | $35,539,314 | |
| WAT | Waters Corp /De/ | +3,759 | 30,206 | $11,328,458 | |
| QURE | uniQure N.V. | +1,328 | 208,170 | $9,588,310 | |
| LLY | ELI LILLY & Co | +384 | 35,000 | $41,980,053 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ABSI | Absci Corp | −970,432 | 894,374 | $10,365,794 | |
| OPRX | OptimizeRx Corp | −379,022 | 350,347 | $2,003,984 | |
| ATEC | Alphatec Holdings, Inc. | −373,820 | 449,943 | $3,892,006 | |
| RCUS | Arcus Biosciences, Inc. | −288,008 | 919,266 | $28,340,970 | |
| BSX | Boston Scientific Corp | −268,287 | 180,481 | $7,702,929 | |
| WAY | Waystar Holding Corp. | −239,072 | 203,986 | $4,187,832 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | −222,676 | 398,782 | $7,162,124 | |
| LIVN | LivaNova PLC | −193,436 | 210,529 | $17,311,799 | |
| NVST | Envista Holdings Corp | −157,777 | 553,916 | $14,595,686 | |
| DXCM | Dexcom Inc | −155,055 | 534,767 | $36,016,557 | |
| ERAS | Erasca, Inc. | −148,018 | 258,684 | $4,739,090 | |
| AORT | Artivion, Inc. | −113,074 | 138,940 | $3,121,981 | |
| LUNG | Pulmonx Corp | −109,072 | 646,564 | $840,533 | |
| URGN | UroGen Pharma Ltd. | −100,936 | 174,064 | $6,405,555 | |
| XENE | Xenon Pharmaceuticals Inc. | −99,656 | 397,379 | $23,985,796 | |
| MMED | MiniMed Group, Inc. | −90,878 | 226,446 | $3,385,367 | |
| CDNA | CareDx, Inc. | −88,961 | 202,417 | $5,768,884 | |
| SYK | Stryker Corp | −86,798 | 67,973 | $21,400,619 | |
| BCRX | Biocryst Pharmaceuticals Inc | −83,820 | 1,624,279 | $16,242,790 | |
| ANIP | Ani Pharmaceuticals Inc | −77,668 | 202,907 | $16,796,641 | |
| EYPT | EyePoint, Inc. | −66,637 | 1,288,163 | $18,420,730 | |
| ADPT | Adaptive Biotechnologies Corp | −64,831 | 486,984 | $0 | |
| SIBN | SI-BONE, Inc. | −44,867 | 328,686 | $5,364,155 | |
| ZBH | Zimmer Biomet Holdings, Inc. | −37,000 | 232,557 | $20,020,832 | |
| ANNX | Annexon, Inc. | −32,984 | 641,029 | $3,660,275 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
17 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| INBX | Inhibrx Biosciences, Inc. | 256,950 | $24,346,012 | |
| UNH | Unitedhealth Group Inc | 55,921 | $23,242,445 | |
| INDV | Indivior Pharmaceuticals, Inc. | 364,269 | $14,945,957 | |
| AVTX | Avalo Therapeutics, Inc. | 766,290 | $14,161,039 | |
| ANRO | Alto Neuroscience, Inc. | 429,035 | $11,322,233 | |
| ORKA | Oruka Therapeutics, Inc. | 113,188 | $10,772,101 | |
| TARS | Tarsus Pharmaceuticals, Inc. | 150,000 | $9,441,000 | |
| CYRX | Cryoport, Inc. | 508,324 | $7,980,686 | |
| CLYM | Climb Bio, Inc. | 563,484 | $7,347,831 | |
| RMD | Resmed Inc | 32,983 | $6,427,727 | |
| AVAH | Aveanna Healthcare Holdings, Inc. | 714,451 | $6,122,845 | |
| SI | Shoulder Innovations, Inc. | 226,212 | $4,587,579 | |
| EIKN | Eikon Therapeutics, Inc. | 256,053 | $3,341,491 | |
| VTRS | Viatris Inc | 200,000 | $3,176,000 | |
| AXSM | Axsome Therapeutics, Inc. | 10,000 | $2,447,700 | |
| COAG | Hemab Therapeutics Holdings, Inc. | 45,000 | $1,652,850 | |
| SPRY | ARS Pharmaceuticals, Inc. | 102,700 | $822,627 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| QGEN | Qiagen N.V. | 500,000 | $20,020,000 | |
| ABBV | AbbVie Inc. | 75,000 | $16,311,750 | |
| ILMN | Illumina, Inc. | 110,370 | $13,604,206 | |
| EW | Edwards Lifesciences Corp | 167,155 | $13,385,772 | |
| NBIX | Neurocrine Biosciences Inc | 99,069 | $13,051,350 | |
| KNSA | Kiniksa Pharmaceuticals International, plc | 259,184 | $12,479,709 | |
| MCK | Mckesson Corp | 12,676 | $10,969,303 | |
| AXGN | Axogen, Inc. | 268,160 | $8,884,140 | |
| IDXX | Idexx Laboratories Inc /De | 15,000 | $8,428,350 | |
| APGE | Apogee Therapeutics, Inc. | 77,686 | $6,538,830 | |
| COO | Cooper Companies, Inc. | 89,883 | $6,426,634 | |
| TNGX | Tango Therapeutics, Inc. | 266,127 | $5,567,376 | |
| RARE | Ultragenyx Pharmaceutical Inc. | 235,000 | $4,923,250 | |
| SUPN | Supernus Pharmaceuticals, Inc. | 85,062 | $4,396,854 | |
| CAI | Caris Life Sciences, Inc. | 229,912 | $4,110,826 | |
| CVRX | CVRx, Inc. | 429,507 | $4,063,136 | |
| WGS | GeneDx Holdings Corp. | 50,778 | $3,260,963 | |
| VCYT | Veracyte, Inc. | 101,237 | $3,260,843 | |
| CMPS | COMPASS Pathways plc | 554,411 | $3,065,892 | |
| SLDB | Solid Biosciences Inc. | 308,844 | $2,223,676 | |
| BFLY | Butterfly Network, Inc. | 544,477 | $2,199,687 | |
| QDEL | QuidelOrtho Corp | 101,764 | $1,671,982 | |
| RXST | RxSight, Inc. | 249,989 | $1,539,932 | |
| QTRX | Quanterix Corp | 341,453 | $1,201,914 | |
| PLSE | Pulse Biosciences, Inc. | 50,125 | $1,082,198 | |
| No positions match the current search. | ||||
76 tracked positions ·
$963,241,457 total
· filing declares
77 positions · $976,827,960
· as of Jun 30, 2026
Showing 1–50
of 76 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Added | 800,173 | $44,169,549 | 4.59% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Added | 35,000 | $41,980,053 | 4.36% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
Added | 391,791 | $40,530,778 | 4.21% | |
| DXCM |
Dexcom Inc
Healthcare
|
Reduced | 534,767 | $36,016,557 | 3.74% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
Added | 435,691 | $35,539,314 | 3.69% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Reduced | 919,266 | $28,340,970 | 2.94% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 485,661 | $26,065,425 | 2.71% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Added | 1,377,576 | $25,306,071 | 2.63% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Added | 669,046 | $24,828,297 | 2.58% | |
| INBX |
Inhibrx Biosciences, Inc.
Healthcare
|
NEW | 256,950 | $24,346,012 | 2.53% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 397,379 | $23,985,796 | 2.49% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Added | 577,036 | $23,444,972 | 2.43% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
NEW | 55,921 | $23,242,445 | 2.41% | |
| SYK |
Stryker Corp
Healthcare
|
Reduced | 67,973 | $21,400,619 | 2.22% | |
| IQV |
Iqvia Holdings Inc.
Healthcare
|
Added | 105,811 | $20,444,801 | 2.12% | |
| ZBH |
Zimmer Biomet Holdings, Inc.
Healthcare
|
Reduced | 232,557 | $20,020,832 | 2.08% | |
| PODD |
Insulet Corp
Healthcare
|
Reduced | 131,378 | $20,002,300 | 2.08% | |
| ASMB |
Assembly Biosciences, Inc.
Healthcare
|
Added | 721,181 | $19,818,053 | 2.06% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Reduced | 877,256 | $19,176,816 | 1.99% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
Reduced | 1,288,163 | $18,420,730 | 1.91% | |
| THC |
Tenet Healthcare Corp
Healthcare
|
Added | 97,280 | $18,199,142 | 1.89% | |
| LIVN |
LivaNova PLC
Healthcare
|
Reduced | 210,529 | $17,311,799 | 1.80% | |
| ANIP |
Ani Pharmaceuticals Inc
Healthcare
|
Reduced | 202,907 | $16,796,641 | 1.74% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
Reduced | 1,624,279 | $16,242,790 | 1.69% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Added | 50,672 | $15,253,792 | 1.58% | |
| INDV |
Indivior Pharmaceuticals, Inc.
Healthcare
|
NEW | 364,269 | $14,945,957 | 1.55% | |
| NVST |
Envista Holdings Corp
Healthcare
|
Reduced | 553,916 | $14,595,686 | 1.52% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
Added | 205,053 | $14,394,720 | 1.49% | |
| XERS |
Xeris Biopharma Holdings, Inc.
Healthcare
|
Added | 1,807,621 | $14,316,358 | 1.49% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
NEW | 766,290 | $14,161,039 | 1.47% | |
| FDMT |
4D Molecular Therapeutics, Inc.
Healthcare
|
Added | 948,184 | $12,610,847 | 1.31% | |
| IMNM |
Immunome Inc.
Healthcare
|
Added | 594,202 | $12,591,140 | 1.31% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Added | 355,443 | $11,630,094 | 1.21% | |
| WAT |
Waters Corp /De/
Healthcare
|
Added | 30,206 | $11,328,458 | 1.18% | |
| ANRO |
Alto Neuroscience, Inc.
Healthcare
|
NEW | 429,035 | $11,322,233 | 1.18% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
NEW | 113,188 | $10,772,101 | 1.12% | |
| ABSI |
Absci Corp
Healthcare
|
Reduced | 894,374 | $10,365,794 | 1.08% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 380,354 | $10,261,950 | 1.07% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Added | 253,365 | $9,805,225 | 1.02% | |
| QURE |
uniQure N.V.
Healthcare
|
Added | 208,170 | $9,588,310 | 1.00% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
NEW | 150,000 | $9,441,000 | 0.98% | |
| AMRX |
Amneal Pharmaceuticals, Inc.
Healthcare
|
Added | 541,190 | $9,367,998 | 0.97% | |
| IRTC |
iRhythm Holdings, Inc.
Healthcare
|
Added | 67,267 | $8,001,409 | 0.83% | |
| CYRX |
Cryoport, Inc.
Industrials
|
NEW | 508,324 | $7,980,686 | 0.83% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Reduced | 180,481 | $7,702,929 | 0.80% | |
| CLYM |
Climb Bio, Inc.
Healthcare
|
NEW | 563,484 | $7,347,831 | 0.76% | |
| AMLX |
Amylyx Pharmaceuticals, Inc.
Healthcare
|
Reduced | 398,782 | $7,162,124 | 0.74% | |
| UPB |
Upstream Bio, Inc.
Healthcare
|
Added | 935,247 | $6,471,909 | 0.67% | |
| RMD |
Resmed Inc
Healthcare
|
NEW | 32,983 | $6,427,727 | 0.67% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
Reduced | 174,064 | $6,405,555 | 0.66% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.